A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
about
Analysis of preterm deliveries below 35 weeks' gestation in a tertiary referral hospital in the UK. A case-control survey.Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injuryAlpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro.Pathway analysis of genetic factors associated with spontaneous preterm birth and pre-labor preterm rupture of membranes.A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitroA molecular signature of an arrest of descent in human parturitionBleeding per vaginam is associated with funisitis in women with preterm prelabour rupture of the fetal membranes.Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term.Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.Placental lesions associated with acute atherosis.High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm laborSynergy and interactions among biological pathways leading to preterm premature rupture of membranes.Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.Maternal and neonatal epidemiological features in clinical subtypes of preterm birth.Meta-Analysis of Maternal and Fetal Transcriptomic Data Elucidates the Role of Adaptive and Innate Immunity in Preterm Birth.
P2860
Q33567311-A2E9E3A3-18B8-44FA-9A0E-754AFCF67F5FQ34146989-35754737-B301-4050-928C-D34FABC141A3Q34154820-B70C8868-9315-44D7-AE57-C2ACB885594BQ34272675-3EC6EF3C-7BEB-41A6-BB34-87D8D6FD367AQ34340129-9E6102A2-6FE0-4DCE-A0C5-F14F58FEA577Q34568696-3F94E06D-9A94-4CFB-A5DE-2F6BE1E56046Q34627401-00BF18E2-D916-4566-B4CC-55B57CD5E79AQ34645135-C92BF8A9-DD3B-43DF-9C87-79623B4F6677Q34785817-0E5DBABC-6EDF-471A-940E-14140FF187B6Q34989601-8E95F095-C043-4C06-9281-7EB70CD2BF5AQ35015402-6DEC9F80-77F8-40B0-A0E4-60C9D021C520Q35558666-4F963241-1472-46BD-9854-0BEE6EF0CE83Q36165666-8B0663AF-3BFD-49E2-B64E-782BC666883FQ38212803-2E273098-5569-48BC-9EB2-97FAFDD6FB22Q40196259-6B1A87B1-9732-4EF5-99BB-BFA3DFC1D45DQ40230103-8BB9AC00-63A8-4342-88F1-085112F6964FQ41649476-67880427-4F2E-4D8C-BD39-9396E0A4125FQ55011065-54DF6A28-630C-463D-80EE-DC3BBDF2C633
P2860
A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@ast
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@en
type
label
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@ast
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@en
prefLabel
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@ast
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@en
P2093
P2860
P1476
A link between a hemostatic di ...... ssue factor pathway inhibitor.
@en
P2093
Bo Hyun Yoon
Debra Hoppensteadt
Francesca Gotsch
Jawed Fareed
Jimmy Espinoza
Juan Pedro Kusanovic
Nandor Gabor Than
Offer Erez
Roberto Romero
Shali Mazaki-Tovi
P2860
P304
P356
10.1080/14767050802361807
P577
2008-10-01T00:00:00Z